The grant from the Israel-US Binational Industrial Research and Development (BIRD) Foundation will go towards the further development of the platform, which automates the conduct of trials in a bid to reduce the cost, time, and resources used running them.
The two companies are working on ways to screen patients and connect them to clinical trial sites that eliminate manual processes involved in data management and patient enrolment.
